Early research (Phase 1)Study completedNCT01675284
What this trial is testing
A Phase I Study to Evaluate the Safety, Reactogenicity, and Humoral Immune Responses to an Inactivated H5N1 Influenza Vaccine
Who this might be right for
Bird FluAvian InfluenzaInfluenza A(H5N1)
Medigen Biotechnology Corporation 36